Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
about
Role of Myeloperoxidase in Patients with Chronic Kidney DiseaseRole of lipotoxicity in endothelial dysfunctionModified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsCirculating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in ChineseHDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approachEffect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney diseaseDisorders of lipid metabolism and chronic kidney disease in the elderlyReverse cholesterol transport pathway in experimental chronic renal failure.Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney diseaseSerum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama StudyMetabolite profiling identifies markers of uremia.Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability.Lycopene ameliorates renal function in rats with streptozotocin-induced diabetes.Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP)Integrative biology identifies shared transcriptional networks in CKD.Association of dyslipidemia with renal outcomes in chronic kidney disease.Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy.Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.Plasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria.Protective Effects of Luteolin on Diabetic Nephropathy in STZ-Induced Diabetic RatsAtorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysisIncident chronic kidney disease and newly developed complications related to renal dysfunction in an elderly population during 5 years: a community-based elderly population cohort study.Nonesterified fatty acids and cardiovascular mortality in elderly men with CKDMild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calciumEffect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial.Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal studySalutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.Very Low Density Lipoprotein Metabolism in Patients with Chronic Kidney Disease.Serum metabolomic profiles from patients with acute kidney injury: a pilot studyPCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFRDi (2-ethylhexyl) Phthalate Exposure Impairs Growth of Antral Follicle in MiceSerum amyloid A in uremic HDL promotes inflammationNovel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.Association between high-density lipoprotein cholesterol and renal function in elderly hypertension: a cross-sectional study in Chinese population.Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.Exploring metabolic dysfunction in chronic kidney disease.
P2860
Q26748996-BB14988D-C8F8-4D66-88EC-AA5BD2E57903Q27000731-B3F484C1-4721-428B-A340-084E051A276EQ28074264-6CEE540D-54CF-4AFF-8888-CCFF3B9CF5D9Q28477784-27C41339-F38B-4425-A5A5-B4259A209367Q28481613-E5515EFC-3863-4069-8A6B-7FCADDD38140Q28565167-78359FD7-BB67-4B97-B4FA-F87544789B2EQ33589563-58043739-72FC-4B7C-9229-8151E80F4835Q33620325-775CB477-06C6-489F-9BDA-4A2C67CE1A1BQ33776181-8108CA76-3589-4405-8CBC-A865A69B769EQ33901943-841202B6-535F-4E42-B1F3-55D00E45A714Q33918753-66B98F1C-5924-4D78-BF40-4B875B8C7A46Q33979275-1C04655F-E445-4CD4-AE21-31D99934DC26Q33999350-8073B7A9-2782-4B69-B905-707976CC6F75Q34121474-CDF66F7C-2936-412B-982E-F207386AD75CQ34308238-E40999F0-A825-493F-9738-BFDAD9E6CE70Q34405404-22B007D8-87E0-41F3-9B19-C4517CF409AAQ34408854-C8BD1722-5A25-456A-B990-E646175E3522Q34427636-3EEF1103-28D4-4133-850E-C5F5548ADBFEQ34580123-BBBF480E-5ECC-46FD-B130-526B333F1945Q34595011-4F8787AD-72F2-4436-833C-F85B9FC7305EQ34652243-52E7FD13-88F6-4E84-98EE-E13BC8FB0037Q34662899-97DE0A32-6CE6-4A5A-8092-92828AAF4ABDQ34974519-47C96D2C-0ED5-43D2-8EEB-A241C0BF1EA7Q35030586-7F9ED6EE-2D03-4C4E-8773-EFD6E2159475Q35075773-CC284D49-411D-402E-B3F8-92513BC53475Q35278551-77AF43C4-7DB5-44D3-9050-C60EF738A789Q35610709-BFCFE9B2-C637-4935-94E1-862997D3F099Q35667598-1E65E680-E4A2-4A76-AF79-5EF633AA33C0Q35735742-8D39AFA8-C949-4891-88A5-0675FEA7D0E3Q35747579-4B8B1BF8-517A-4D61-86B3-15F49B3D60BEQ35760064-6D1B4C6A-54A5-4BED-83D8-D355EFAC9A97Q35868708-9ACB0EFF-BC18-49A0-90C2-563D7F48E226Q35885617-6AEF5D28-365B-4324-AAC3-1575D9E81BFEQ35901123-66ECDA3F-871C-4A36-AC32-85E9D90B1A8FQ35914630-367A820B-955C-4D83-B421-7220EE882EE8Q35917487-26205E24-DCD3-4A2D-A29A-62445CFE846CQ35990607-A112F2E1-21FC-4F23-80A6-3F78ECD58914Q36009267-B413A6CA-DE0A-4FD2-AD8A-F1ACE08BE3DBQ36032978-808B2762-2425-4916-86A6-E33F832392B6Q36123347-22739340-6DD5-46FA-BC10-AD6C4D6E8A6D
P2860
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Dyslipidemia of chronic renal ...... s, and potential consequences.
@ast
Dyslipidemia of chronic renal ...... s, and potential consequences.
@en
type
label
Dyslipidemia of chronic renal ...... s, and potential consequences.
@ast
Dyslipidemia of chronic renal ...... s, and potential consequences.
@en
prefLabel
Dyslipidemia of chronic renal ...... s, and potential consequences.
@ast
Dyslipidemia of chronic renal ...... s, and potential consequences.
@en
P2860
P1476
Dyslipidemia of chronic renal ...... s, and potential consequences.
@en
P2093
P2860
P304
P356
10.1152/AJPRENAL.00099.2005
P577
2006-02-01T00:00:00Z